Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $261,249 (100.0% shares, 0.0% debt)

Holdings (23)

CYTK CYTOKINETICS INC 14.3%
Value ($000) $37,416 Shares 448,144 Est. Cost $39.36 Unrealized -8.0%
CRNX CRINETICS PHARMACEUTICALS IN 10.7%
Value ($000) $28,006 Shares 787,132 Est. Cost $18.62 Unrealized +64.7%
KALV KALVISTA PHARMACEUTICALS INC 8.5%
Value ($000) $22,143 Shares 1,807,563 Est. Cost $7.51 Unrealized +21.1%
ARGX ARGENX SE 7.5%
Value ($000) $19,469 Shares 51,175 Est. Cost $394.19 Unrealized
CYMABAY THERAPEUTICS INC 6.8%
Value ($000) $17,721 Shares 750,250 Est. Cost $3.60 Unrealized
ASND ASCENDIS PHARMA A/S 6.4%
Value ($000) $16,595 Shares 131,759 Est. Cost $110.99 Unrealized
AMLX AMYLYX PHARMACEUTICALS INC 6.2%
Value ($000) $16,181 Shares 1,099,268 Est. Cost $20.02 Unrealized -23.4%
ANAB ANAPTYSBIO INC 5.4%
Value ($000) $14,229 Shares 664,276 Est. Cost $18.84 Unrealized -8.5%
BMRN BIOMARIN PHARMACEUTICAL INC 4.4%
Value ($000) $11,492 Shares 119,188 Est. Cost $92.92 Unrealized -4.8%
SNDX SYNDAX PHARMACEUTICALS INC 4.3%
Value ($000) $11,211 Shares 518,799 Est. Cost $19.32 Unrealized -20.5%
MERUS N V 4.1%
Value ($000) $10,707 Shares 389,333 Est. Cost $27.10 Unrealized
ITEOS THERAPEUTICS INC 3.5%
Value ($000) $9,069 Shares 828,232 Est. Cost $14.98 Unrealized
APLS APELLIS PHARMACEUTICALS INC 3.3%
Value ($000) $8,556 Shares 142,927 Est. Cost $50.73 Unrealized 0.0%
BIIB BIOGEN INC 3.2%
Value ($000) $8,402 Shares 32,469 Est. Cost $275.18 Unrealized -10.7%
ASTRIA THERAPEUTICS INC 2.9%
Value ($000) $7,608 Shares 990,663 Est. Cost $7.99 Unrealized
MORPHIC HLDG INC 2.3%
Value ($000) $6,132 Shares 212,343 Est. Cost $27.88 Unrealized
COGT COGENT BIOSCIENCES INC 1.7%
Value ($000) $4,449 Shares 756,681 Est. Cost $11.61 Unrealized -34.0%
IRON DISC MEDICINE INC 1.4%
Value ($000) $3,742 Shares 64,784 Est. Cost $51.20 Unrealized 0.0%
FOLD AMICUS THERAPEUTICS INC 1.1%
Value ($000) $2,838 Shares 199,973 Est. Cost $11.35 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 0.8%
Value ($000) $1,977 Shares 10,327 Est. Cost $170.34 Unrealized 0.0%
PHAT PHATHOM PHARMACEUTICALS INC 0.6%
Value ($000) $1,461 Shares 160,075 Est. Cost $8.62 Unrealized 0.0%
JASPER THERAPEUTICS INC 0.4%
Value ($000) $1,094 Shares 1,386,215 Est. Cost $0.70 Unrealized
AMBRX BIOPHARMA INC 0.3%
Value ($000) $752 Shares 52,781 Est. Cost $14.24 Unrealized